Annual EBIT
$7.13 M
+$44.79 M+118.92%
December 1, 2023
Summary
- As of February 7, 2025, ORMP annual earnings before interest & taxes is $7.13 million, with the most recent change of +$44.79 million (+118.92%) on December 1, 2023.
- During the last 3 years, ORMP annual EBIT has risen by +$14.43 million (+197.59%).
- ORMP annual EBIT is now at all-time high.
Performance
ORMP EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$3.09 M
-$14.19 M-127.83%
September 1, 2024
Summary
- As of February 7, 2025, ORMP quarterly earnings before interest & taxes is -$3.09 million, with the most recent change of -$14.19 million (-127.83%) on September 1, 2024.
- Over the past year, ORMP quarterly EBIT has dropped by -$17.60 million (-121.29%).
- ORMP quarterly EBIT is now -121.29% below its all-time high of $14.51 million, reached on December 1, 2023.
Performance
ORMP Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
$24.64 M
-$631.00 K-2.50%
September 1, 2024
Summary
- As of February 7, 2025, ORMP TTM earnings before interest & taxes is $24.64 million, with the most recent change of -$631.00 thousand (-2.50%) on September 1, 2024.
- Over the past year, ORMP TTM EBIT has increased by +$17.52 million (+245.87%).
- ORMP TTM EBIT is now -2.50% below its all-time high of $25.27 million, reached on June 1, 2024.
Performance
ORMP TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
ORMP EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +118.9% | -121.3% | +245.9% |
| 3 y3 years | +197.6% | +72.9% | +164.8% |
| 5 y5 years | +148.7% | -6.6% | +293.0% |
ORMP EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +118.9% | -121.3% | +72.9% | -2.5% | +163.9% |
| 5 y | 5-year | at high | +118.9% | -121.3% | +72.9% | -2.5% | +163.9% |
| alltime | all time | at high | +118.9% | -121.3% | +72.9% | -2.5% | +163.9% |
Oramed Pharmaceuticals EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.09 M(-127.8%) | $24.64 M(-2.5%) |
| Jun 2024 | - | $11.10 M(+422.1%) | $25.27 M(+96.5%) |
| Mar 2024 | - | $2.13 M(-85.3%) | $12.86 M(+80.5%) |
| Dec 2023 | $7.13 M(-118.9%) | $14.51 M(-690.2%) | $7.13 M(-144.2%) |
| Sep 2023 | - | -$2.46 M(+87.2%) | -$16.12 M(-22.6%) |
| Jun 2023 | - | -$1.31 M(-63.6%) | -$20.81 M(-32.7%) |
| Mar 2023 | - | -$3.61 M(-58.7%) | -$30.92 M(-19.8%) |
| Dec 2022 | -$37.66 M(+207.4%) | -$8.74 M(+22.1%) | -$38.56 M(+2.2%) |
| Sep 2022 | - | -$7.15 M(-37.3%) | -$37.74 M(-0.7%) |
| Jun 2022 | - | -$11.42 M(+1.5%) | -$38.00 M(+16.2%) |
| Mar 2022 | - | -$11.25 M(+42.0%) | -$32.70 M(+24.3%) |
| Dec 2021 | -$12.25 M(-49.4%) | - | - |
| Nov 2021 | - | -$7.92 M(+6.9%) | -$26.32 M(+9.9%) |
| Aug 2021 | -$24.22 M(+231.8%) | -$7.41 M(+21.1%) | -$23.95 M(+22.5%) |
| May 2021 | - | -$6.12 M(+25.7%) | -$19.56 M(+24.5%) |
| Feb 2021 | - | -$4.87 M(-12.4%) | -$15.72 M(+5.6%) |
| Dec 2020 | -$7.30 M(-37.9%) | - | - |
| Nov 2020 | - | -$5.56 M(+84.2%) | -$14.89 M(+26.6%) |
| Aug 2020 | -$11.76 M(-19.6%) | -$3.02 M(+32.7%) | -$11.76 M(+1.0%) |
| May 2020 | - | -$2.27 M(-43.7%) | -$11.64 M(-13.3%) |
| Feb 2020 | - | -$4.04 M(+66.2%) | -$13.42 M(+5.1%) |
| Nov 2019 | - | -$2.43 M(-16.2%) | -$12.77 M(-12.7%) |
| Aug 2019 | -$14.63 M(+8.2%) | -$2.90 M(-28.6%) | -$14.63 M(-5.8%) |
| May 2019 | - | -$4.06 M(+20.0%) | -$15.53 M(-1.7%) |
| Feb 2019 | - | -$3.38 M(-21.2%) | -$15.80 M(+3.2%) |
| Nov 2018 | - | -$4.29 M(+13.1%) | -$15.31 M(+13.2%) |
| Aug 2018 | -$13.53 M(+25.6%) | -$3.80 M(-12.2%) | -$13.53 M(+2.6%) |
| May 2018 | - | -$4.33 M(+49.4%) | -$13.18 M(+22.0%) |
| Feb 2018 | - | -$2.89 M(+15.3%) | -$10.80 M(-2.4%) |
| Nov 2017 | - | -$2.51 M(-27.3%) | -$11.07 M(+2.8%) |
| Aug 2017 | -$10.77 M(+7.6%) | -$3.45 M(+77.5%) | -$10.77 M(-3.7%) |
| May 2017 | - | -$1.95 M(-38.5%) | -$11.19 M(-0.2%) |
| Feb 2017 | - | -$3.16 M(+42.9%) | -$11.22 M(+14.0%) |
| Nov 2016 | - | -$2.21 M(-42.8%) | -$9.84 M(-1.6%) |
| Aug 2016 | -$10.01 M(+35.6%) | -$3.87 M(+96.1%) | -$10.00 M(+18.9%) |
| May 2016 | - | -$1.97 M(+10.6%) | -$8.41 M(+4.9%) |
| Feb 2016 | - | -$1.78 M(-24.8%) | -$8.02 M(+1.9%) |
| Nov 2015 | - | -$2.37 M(+4.2%) | -$7.87 M(+6.8%) |
| Aug 2015 | -$7.38 M | -$2.28 M(+43.9%) | -$7.37 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| May 2015 | - | -$1.58 M(-3.2%) | -$6.94 M(-3.4%) |
| Feb 2015 | - | -$1.64 M(-12.7%) | -$7.18 M(+7.9%) |
| Nov 2014 | - | -$1.88 M(+1.4%) | -$6.66 M(+12.7%) |
| Aug 2014 | -$5.91 M(+37.2%) | -$1.85 M(+1.4%) | -$5.91 M(+12.3%) |
| May 2014 | - | -$1.82 M(+64.0%) | -$5.26 M(+12.2%) |
| Feb 2014 | - | -$1.11 M(-0.9%) | -$4.69 M(-1.7%) |
| Nov 2013 | - | -$1.12 M(-6.6%) | -$4.77 M(+10.7%) |
| Aug 2013 | -$4.30 M(+49.2%) | -$1.20 M(-3.9%) | -$4.30 M(+7.3%) |
| May 2013 | - | -$1.25 M(+4.8%) | -$4.01 M(+21.5%) |
| Feb 2013 | - | -$1.19 M(+80.9%) | -$3.30 M(+7.0%) |
| Nov 2012 | - | -$659.60 K(-27.4%) | -$3.08 M(+7.0%) |
| Aug 2012 | -$2.88 M(+84.1%) | -$909.00 K(+68.3%) | -$2.88 M(+4.2%) |
| May 2012 | - | -$540.10 K(-44.7%) | -$2.77 M(+57.0%) |
| Feb 2012 | - | -$975.90 K(+112.6%) | -$1.76 M(+23.6%) |
| Nov 2011 | - | -$459.00 K(-42.0%) | -$1.43 M(-9.0%) |
| Aug 2011 | -$1.57 M(-46.9%) | -$791.80 K(-270.6%) | -$1.57 M(-18.5%) |
| May 2011 | - | $464.10 K(-172.6%) | -$1.92 M(-39.7%) |
| Feb 2011 | - | -$639.40 K(+6.7%) | -$3.19 M(+8.5%) |
| Nov 2010 | - | -$599.40 K(-47.8%) | -$2.94 M(-0.3%) |
| Aug 2010 | -$2.95 M(+7.4%) | -$1.15 M(+43.4%) | -$2.95 M(+33.8%) |
| May 2010 | - | -$801.00 K(+105.7%) | -$2.20 M(+15.0%) |
| Feb 2010 | - | -$389.40 K(-36.1%) | -$1.92 M(-11.8%) |
| Nov 2009 | - | -$609.10 K(+50.7%) | -$2.17 M(-21.4%) |
| Aug 2009 | -$2.75 M(+2.4%) | -$404.10 K(-21.3%) | -$2.77 M(-20.3%) |
| May 2009 | - | -$513.30 K(-20.6%) | -$3.47 M(-8.7%) |
| Feb 2009 | - | -$646.50 K(-46.2%) | -$3.80 M(+9.0%) |
| Nov 2008 | - | -$1.20 M(+8.4%) | -$3.49 M(+31.8%) |
| Aug 2008 | -$2.68 M(-14.4%) | -$1.11 M(+31.2%) | -$2.65 M(-34.3%) |
| May 2008 | - | -$845.00 K(+153.4%) | -$4.03 M(+15.8%) |
| Feb 2008 | - | -$333.50 K(-7.6%) | -$3.48 M(+1.9%) |
| Nov 2007 | - | -$361.00 K(-85.5%) | -$3.42 M(+9.1%) |
| Aug 2007 | -$3.13 M(+658.5%) | -$2.49 M(+746.2%) | -$3.13 M(+241.3%) |
| May 2007 | - | -$294.60 K(+9.8%) | -$917.70 K(+22.4%) |
| Feb 2007 | - | -$268.30 K(+252.6%) | -$750.00 K(+55.2%) |
| Nov 2006 | - | -$76.10 K(-72.7%) | -$483.30 K(+17.2%) |
| Aug 2006 | -$412.90 K(+821.7%) | -$278.70 K(+119.6%) | -$412.20 K(+208.8%) |
| May 2006 | - | -$126.90 K(+7831.3%) | -$133.50 K(+1922.7%) |
| Feb 2006 | - | -$1600.00(-68.0%) | -$6600.00(+32.0%) |
| Nov 2005 | - | -$5000.00 | -$5000.00 |
| Aug 2005 | -$44.80 K | - | - |
FAQ
- What is Oramed Pharmaceuticals annual earnings before interest & taxes?
- What is the all time high annual EBIT for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals annual EBIT year-on-year change?
- What is Oramed Pharmaceuticals quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals quarterly EBIT year-on-year change?
- What is Oramed Pharmaceuticals TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Oramed Pharmaceuticals?
- What is Oramed Pharmaceuticals TTM EBIT year-on-year change?
What is Oramed Pharmaceuticals annual earnings before interest & taxes?
The current annual EBIT of ORMP is $7.13 M
What is the all time high annual EBIT for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high annual earnings before interest & taxes is $7.13 M
What is Oramed Pharmaceuticals annual EBIT year-on-year change?
Over the past year, ORMP annual earnings before interest & taxes has changed by +$44.79 M (+118.92%)
What is Oramed Pharmaceuticals quarterly earnings before interest & taxes?
The current quarterly EBIT of ORMP is -$3.09 M
What is the all time high quarterly EBIT for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high quarterly earnings before interest & taxes is $14.51 M
What is Oramed Pharmaceuticals quarterly EBIT year-on-year change?
Over the past year, ORMP quarterly earnings before interest & taxes has changed by -$17.60 M (-121.29%)
What is Oramed Pharmaceuticals TTM earnings before interest & taxes?
The current TTM EBIT of ORMP is $24.64 M
What is the all time high TTM EBIT for Oramed Pharmaceuticals?
Oramed Pharmaceuticals all-time high TTM earnings before interest & taxes is $25.27 M
What is Oramed Pharmaceuticals TTM EBIT year-on-year change?
Over the past year, ORMP TTM earnings before interest & taxes has changed by +$17.52 M (+245.87%)